<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of children are among the pathologies which have benefited the most of the improvements of therapy since twenty years </plain></SENT>
<SENT sid="1" pm="."><plain>Classically, the therapy of Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> included radiotherapy; nowadays, the role of chemotherapy becomes more important </plain></SENT>
<SENT sid="2" pm="."><plain>For non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, the role of surgery and radiotherapy has quite completely disappeared, and the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are cured by chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>This review will focus on Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and two of the most frequent non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, namely Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Most recent advances in treatment and management of sequelae are presented </plain></SENT>
</text></document>